ArticleACS medicinal chemistry letters2020

Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma.

Zenon Konteatis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.